U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06971991) titled 'qDSA Blood Flow Measurement in Patients Undergoing TAE of the Liver' on May 06.
Brief Summary: The purpose of this research is to evaluate a new technique, quantitative digital subtraction angiography (qDSA), to measure blood flow during liver embolization procedures. Liver transarterial embolization is a way of treating liver tumors by blocking blood flow to it. The qDSA technique could help doctors ensure the blood flow to the tumor is decreased by the right amount by calculating blood flow before, during, and after the procedure. Up to 20 participants will be enrolled for 1 study visit and data collection for up to 6 months.
Stud...